Custom service
Dipeptide Synthesis
Synthesize dipeptides at research or bulk scale with defined protecting groups
Dipeptide Synthesis supports programmes that synthesize dipeptides at research or bulk scale with defined protecting groups. In a typical engagement we plan the protecting-group-flexible synthesis route first, confirm compatibility with racemization-controlled coupling, and release dipeptide with purity and stereochemistry QC on a 2–4 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep protecting-group-flexible synthesis as the primary option and hold racemization-controlled coupling in reserve, so that scale-up never depends on an unproven step.
Dipeptide intermediates for drug synthesis
Sweetener and nutraceutical ingredient candidates
Food-grade production certifications
Sequences where a recombinant expression route is objectively cheaper and faster
Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.
Service Highlights
- Protecting-group-flexible synthesis as the default route, with racemization-controlled coupling held as a proven fallback
- Salt and free-base forms worked into the design where the application requires it
- Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
- Analytical confirmation of every intermediate before the final release
- Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
- Dipeptide with purity and stereochemistry QC delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence analysis
Dipeptide Synthesis is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.
Route selection
Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.
Assembly
The chain is built with protecting-group-flexible synthesis applied where the sequence demands it, with double-coupling at hazard sites.
Cleavage & crude QC
Crude material is characterized so purification targets are set on data, not hope.
Purification
RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.
Release
Dipeptide with purity and stereochemistry QC is documented with the full analytical package and released.
Specifications & timeline
- Turnaround
- 2–4 weeks
- Typical scale
- 0.1 mg – 10 g per sequence
- Chemistry options
- protecting-group-flexible synthesis; racemization-controlled coupling; salt and free-base forms
- Deliverable
- Dipeptide with purity and stereochemistry QC
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
- Shipping
- Ambient with desiccant; blue ice for modified or sensitive peptides
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.